(INNS)
ZAMEROVIMAB(INND)
ZAMEROVIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[RABIES LYSSAVIRUS (RABIES VIRUS, RABV) SPIKE GLYCOPROTEIN G], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-451) [VH (HOMO SAPIENS IGHV1-3*01 (80.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1- 121) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235- 344), CH3 D12 (360), L14 (362) (345-449), CHS (450- 451)) (122-451)], (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-16*01 (86.3%) -IGKJ2*02 (100%), CDR-IMGT [6.3.9](27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'- 214')]; DIMER (230-230'':233-233'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-DG44 CELL LINE, GLYCOFORM ALFA(WHO)
ZAMEROVIMABUM(INN)